Outlook Therapeutics, Inc. (OTLK)
NASDAQ: OTLK · Real-Time Price · USD
1.710
+0.100 (6.21%)
At close: Jun 26, 2026, 4:00 PM EDT
1.696
-0.014 (-0.82%)
After-hours: Jun 26, 2026, 7:59 PM EDT
Outlook Therapeutics Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Outlook Therapeutics stock have an average target of 2.50, with a low estimate of 0.50 and a high estimate of 6.00. The average target predicts an increase of 46.20% from the current stock price of 1.71.
Analyst Consensus: Buy
* Price targets were last updated on Apr 8, 2026.
Analyst Ratings
The average analyst rating for Outlook Therapeutics stock from 4 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 2 | 2 | 1 | 1 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 3 | 3 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| BTIG | BTIG | Hold Downgrades n/a | Hold | Downgrades | n/a | n/a | May 18, 2026 |
| H.C. Wainwright | H.C. Wainwright | Hold Reiterates $0.5 | Hold | Reiterates | $0.5 | -70.76% | Apr 8, 2026 |
| Ascendiant | Ascendiant | Buy Maintains $10 → $6 | Buy | Maintains | $10 → $6 | +250.88% | Mar 11, 2026 |
| Chardan Capital | Chardan Capital | Hold Maintains $3 → $1 | Hold | Maintains | $3 → $1 | -41.52% | Jan 2, 2026 |
Financial Forecast
Revenue This Year
1.20M
from 1.41M
Decreased by -15.11%
Revenue Next Year
45.73M
from 1.20M
Increased by 3,710.63%
EPS This Year
-0.51
from -1.89
EPS Next Year
-0.22
from -0.51
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 2.0M | 132.6M | |
| Avg | 1.2M | 45.7M | |
| Low | 400,000 | 14.0M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 41.5% | 10,953.8% | |
| Avg | -15.1% | 3,710.6% | |
| Low | -71.7% | 1,066.7% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -0.51 | -0.12 | |
| Avg | -0.51 | -0.22 | |
| Low | -0.51 | -0.33 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.